In this week’s video Tyler Laundon talks about the big picture of economic recoveries and how they tend to run much longer than investors think. While the pandemic is still an issue, there are ways to play both the vaccine rollout as well as the (hopefully) subsequent recovery. Tyler zeroes in on one vaccine distribution stock as well as two growth names that are doing very well since a spin out in 2019. Stocks mentioned include: EVBG, CYRX, CRNC and NUAN.
Get It While It’s Hot!
Be among the first to see the Cabot Weekly Review when it comes out. Have it delivered right to your inbox every Saturday. Get on the list:
Tyler Laundon is chief analyst of Cabot Small-Cap Confidential and Cabot Early Opportunities. The circulation of Small-Cap Confidential is strictly limited because the undiscovered stocks with sky-high-potential that Tyler recommends are often low-priced and thinly traded. Don’t share these recommendations!Learn More